News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,325 Results
Type
Article (40662)
Company Profile (297)
Press Release (667366)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (207084)
Career Advice (2072)
Deals (35876)
Drug Delivery (100)
Drug Development (82390)
Employer Resources (176)
FDA (16258)
Job Trends (15172)
News (350112)
Policy (32869)
Tag
Academia (2574)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50234)
ALS (90)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (131)
Approvals (16259)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (363)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (212)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (281)
Cancer (2267)
Cardiovascular disease (178)
Career advice (1729)
Career pathing (33)
CAR-T (151)
Cell therapy (428)
Cervical cancer (19)
Clinical research (67034)
Collaboration (846)
Compensation (531)
Complete response letters (21)
COVID-19 (2613)
CRISPR (40)
C-suite (246)
Cystic fibrosis (101)
Data (2213)
Decentralized trials (2)
Denatured (26)
Depression (46)
Diabetes (271)
Diagnostics (6387)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87642)
Editorial (42)
Employer branding (23)
Employer resources (150)
Events (114815)
Executive appointments (737)
FDA (17512)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (106)
Generative AI (20)
Gene therapy (307)
GLP-1 (737)
Government (4462)
Grass and pollen (5)
Guidances (59)
Healthcare (18899)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (30)
Infectious disease (2755)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (97)
Interviews (328)
IPO (16745)
IRA (41)
Job creations (3837)
Job search strategy (1469)
Kidney cancer (10)
Labor market (38)
Layoffs (483)
Leadership (22)
Legal (7959)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (308)
MASH (70)
Medical device (13392)
Medtech (13397)
Mergers & acquisitions (19680)
Metabolic disorders (698)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1948)
NextGen: Class of 2025 (6571)
Non-profit (4499)
Now hiring (40)
Obesity (371)
Opinion (222)
Ovarian cancer (76)
Pain (86)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (235)
Patient recruitment (111)
Peanut (46)
People (58157)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20920)
Phase II (29578)
Phase III (21921)
Pipeline (1192)
Policy (149)
Postmarket research (2573)
Preclinical (8888)
Press Release (64)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (380)
Real estate (6031)
Recruiting (67)
Regulatory (22532)
Reports (46)
Research institute (2343)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3658)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (42)
The Weekly (47)
Vaccines (702)
Venture capitalists (42)
Weight loss (243)
Women's health (38)
Worklife (20)
Date
Today (174)
Last 7 days (874)
Last 30 days (2660)
Last 365 days (33253)
2025 (10747)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32006)
2013 (26894)
2012 (29013)
2011 (29669)
2010 (27706)
Location
Africa (741)
Alabama (58)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (39138)
Australia (6324)
California (6144)
Canada (2016)
China (539)
Colorado (269)
Connecticut (275)
Delaware (148)
Europe (84500)
Florida (919)
Georgia (205)
Idaho (57)
Illinois (538)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (902)
Massachusetts (4616)
Michigan (219)
Minnesota (393)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1739)
New Mexico (29)
New York (1749)
North Carolina (1020)
North Dakota (8)
Northern California (2678)
Ohio (204)
Oklahoma (14)
Oregon (35)
Pennsylvania (1376)
Puerto Rico (13)
Rhode Island (33)
South America (1121)
South Carolina (22)
South Dakota (1)
Southern California (2305)
Tennessee (101)
Texas (913)
United States (23292)
Utah (181)
Virginia (147)
Washington D.C. (62)
Washington State (561)
West Virginia (3)
Wisconsin (54)
708,325 Results for "theravance biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024.
May 13, 2024
·
17 min read
Business
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the fourth quarter of 2023 and full-year ended December 31, 2023.
February 26, 2024
·
23 min read
Theravance Biopharma to Participate in an Upcoming May 2024 Investor Conference
Theravance Biopharma, Inc. will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT and will be hosting in-person meetings with the investment community at the conference.
May 9, 2024
·
1 min read
Business
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024.
April 29, 2024
·
1 min read
Business
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
Theravance Biopharma, Inc. (“Theravance” or the “Company”) (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a Special Advisor to Irenic Capital Management LP (“Irenic”).
December 21, 2023
·
8 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Business
Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the third quarter of 2023.
November 7, 2023
·
23 min read
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Theravance Biopharma to Participate in an Upcoming March 2024 Investor Conference
Theravance Biopharma, Inc. will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference in Boston, MA on Tuesday, March 5 at 10:30 am ET.
February 22, 2024
·
1 min read
Job Trends
Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February
Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent
BioSpace
data.
March 27, 2025
·
2 min read
·
Angela Gabriel
1 of 70,833
Next
